Advertisement
Screener

Vaxart, Inc. (VXRT) Operating Income

Vaxart, Inc. Operating Income

Vaxart, Inc. (VXRT) reported Operating Income of -$13.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-06

  • Vaxart, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$13.17M.
  • Vaxart, Inc. operating income (loss) for the quarter ending 2026-03-31 was $5.17M.
  • Vaxart, Inc. operating income (loss) for the quarter ending 2025-12-31 was $55.42M.
  • Vaxart, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$7.81M.
  • Vaxart, Inc. operating income (loss) for fiscal 2023 was -$83.35M.
  • Vaxart, Inc. operating income (loss) for fiscal 2022 was -$114.59M.
  • Vaxart, Inc. operating income (loss) for fiscal 2021 was -$72.75M.
  • Vaxart, Inc. operating income (loss) for fiscal 2020 was -$30.17M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 month
2026-06-30-$13.17M
10-Q · filed 2026-08-06
-$8.00M
10-Q · filed 2026-08-06
$47.42M
derived: sum of 3 quarters · filed 2026-08-06
$39.61M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$5.17M
S-1 · filed 2026-05-08
$60.60M
derived: sum of 2 quarters · filed 2026-05-08
$52.78M
derived: sum of 3 quarters · filed 2026-05-08
$38.18M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$55.42M
derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08
$47.61M
derived: sum of 2 quarters · filed 2026-05-08
$33.01M
derived: sum of 3 quarters · filed 2026-08-06
$18.07M
S-1 · filed 2026-05-08
2025-09-30-$7.81M
10-Q · filed 2025-11-13
-$22.41M
derived: sum of 2 quarters · filed 2026-08-06
-$37.35M
10-Q · filed 2025-11-13
-$48.84M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$14.60M
10-Q · filed 2026-08-06
-$29.54M
10-Q · filed 2026-08-06
-$41.03M
derived: sum of 3 quarters · filed 2026-08-06
-$55.51M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$14.94M
S-1 · filed 2026-05-08
-$26.43M
derived: sum of 2 quarters · filed 2026-05-08
-$40.90M
derived: sum of 3 quarters · filed 2026-05-08
-$57.16M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$11.49M
derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08
-$25.97M
derived: sum of 2 quarters · filed 2026-05-08
-$42.22M
derived: sum of 3 quarters · filed 2026-05-08
-$66.29M
S-1 · filed 2026-05-08
2024-09-30-$14.47M
10-Q · filed 2025-11-13
-$30.73M
derived: sum of 2 quarters · filed 2025-11-13
-$54.80M
10-Q · filed 2025-11-13
-$71.70M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$16.26M
10-Q · filed 2025-08-13
-$40.33M
10-Q · filed 2025-08-13
-$57.23M
derived: sum of 3 quarters · filed 2025-08-13
-$75.05M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$24.07M
10-Q · filed 2025-05-13
-$40.97M
derived: sum of 2 quarters · filed 2025-05-13
-$58.79M
derived: sum of 3 quarters · filed 2025-05-13
-$81.84M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$16.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
-$34.72M
derived: sum of 2 quarters · filed 2025-03-20
-$57.77M
derived: sum of 3 quarters · filed 2025-03-20
-$83.35M
10-K · filed 2025-03-20
2023-09-30-$17.82M
10-Q · filed 2024-11-13
-$40.88M
derived: sum of 2 quarters · filed 2024-11-13
-$66.45M
10-Q · filed 2024-11-13
-$97.58M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$23.05M
10-Q · filed 2024-08-08
-$48.63M
10-Q · filed 2024-08-08
-$79.76M
derived: sum of 3 quarters · filed 2024-08-08
-$109.19M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$25.57M
10-Q · filed 2024-05-13
-$56.71M
derived: sum of 2 quarters · filed 2024-05-13
-$86.14M
derived: sum of 3 quarters · filed 2024-05-13
-$115.38M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$31.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$60.56M
derived: sum of 2 quarters · filed 2024-03-14
-$89.81M
derived: sum of 3 quarters · filed 2024-03-14
-$114.59M
10-K · filed 2024-03-14
2022-09-30-$29.43M
10-Q · filed 2023-11-02
-$58.67M
derived: sum of 2 quarters · filed 2023-11-02
-$83.45M
10-Q · filed 2023-11-02
-$107.66M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30-$29.25M
10-Q · filed 2023-08-03
-$54.02M
10-Q · filed 2023-08-03
-$78.24M
derived: sum of 3 quarters · filed 2023-08-03
-$95.49M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31-$24.78M
10-Q · filed 2023-05-04
-$48.99M
derived: sum of 2 quarters · filed 2023-05-04
-$66.24M
derived: sum of 3 quarters · filed 2023-05-04
-$82.02M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31-$24.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
-$41.47M
derived: sum of 2 quarters · filed 2023-03-15
-$57.24M
derived: sum of 3 quarters · filed 2023-03-15
-$72.75M
10-K · filed 2023-03-15
2021-09-30-$17.25M
10-Q · filed 2022-11-09
-$33.03M
derived: sum of 2 quarters · filed 2022-11-09
-$48.54M
10-Q · filed 2022-11-09
-$61.90M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$15.78M
10-Q · filed 2022-08-08
-$31.29M
10-Q · filed 2022-08-08
-$44.65M
derived: sum of 3 quarters · filed 2022-08-08
-$52.24M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31-$15.51M
10-Q · filed 2022-05-09
-$28.87M
derived: sum of 2 quarters · filed 2022-05-09
-$36.46M
derived: sum of 3 quarters · filed 2022-05-09
-$44.99M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31-$13.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$20.95M
derived: sum of 2 quarters · filed 2022-02-24
-$29.48M
derived: sum of 3 quarters · filed 2022-02-24
-$30.17M
10-K · filed 2022-02-24
2020-09-30-$7.59M
10-Q · filed 2021-11-04
-$16.11M
derived: sum of 2 quarters · filed 2021-11-04
-$16.81M
10-Q · filed 2021-11-04
-$22.43M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$8.53M
10-Q · filed 2021-08-05
-$9.22M
10-Q · filed 2021-08-05
-$14.85M
derived: sum of 3 quarters · filed 2022-02-24
-$19.56M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$694.00K
10-Q · filed 2021-05-06
-$6.32M
derived: sum of 2 quarters · filed 2022-02-24
-$11.03M
derived: sum of 3 quarters · filed 2022-02-24
-$16.03M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$5.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$10.34M
derived: sum of 2 quarters · filed 2022-02-24
-$15.34M
derived: sum of 3 quarters · filed 2022-02-24
-$15.79M
10-K · filed 2022-02-24
2019-09-30-$4.71M
10-Q · filed 2020-11-12
-$9.71M
derived: sum of 2 quarters · filed 2020-11-12
-$10.16M
10-Q · filed 2020-11-12
-$14.35M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$5.00M
10-Q · filed 2020-08-06
-$5.45M
10-Q · filed 2020-08-06
-$9.63M
derived: sum of 3 quarters · filed 2021-02-25
-$15.51M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$448.00K
10-Q · filed 2020-05-12
-$4.63M
derived: sum of 2 quarters · filed 2021-02-25
-$10.51M
derived: sum of 3 quarters · filed 2021-02-25
-$18.29M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$4.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$10.07M
derived: sum of 2 quarters · filed 2021-02-25
-$17.84M
derived: sum of 3 quarters · filed 2021-02-25
-$21.76M
10-K · filed 2021-02-25
2018-09-30-$5.88M
10-Q · filed 2019-11-12
-$13.65M
derived: sum of 2 quarters · filed 2019-11-12
-$17.57M
10-Q · filed 2019-11-12
-$20.47M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$7.78M
10-Q · filed 2019-08-08
-$11.69M
10-Q · filed 2019-08-08
-$14.59M
derived: sum of 3 quarters · filed 2019-08-08
-$16.55M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$3.92M
10-Q · filed 2019-05-09
-$6.82M
derived: sum of 2 quarters · filed 2019-05-09
-$8.77M
derived: sum of 3 quarters · filed 2019-05-09
-$11.89M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$2.90M
10-Q · filed 2018-02-06
-$7.90M
10-Q · filed 2018-02-06
-$7.98M
derived: sum of 3 quarters · filed 2018-11-13
-$10.02M
10-K · filed 2019-02-06
2017-09-30-$1.96M
10-Q · filed 2018-11-13
-$5.00M
10-Q · filed 2017-11-07
-$5.08M
derived: sum of 2 quarters · filed 2018-11-13
-$7.33M
10-Q · filed 2018-11-13
-$15.93M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$3.12M
10-Q · filed 2018-08-10
-$5.37M
10-Q · filed 2018-08-10
-$13.97M
derived: sum of 3 quarters · filed 2018-08-10
-$27.50M
10-K · filed 2017-09-01
2017-03-31-$2.25M
10-Q · filed 2018-05-15
-$3.80M
10-Q · filed 2017-05-08
-$10.85M
derived: sum of 2 quarters · filed 2018-05-15
-$21.90M
10-Q · filed 2017-05-08
-$27.15M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$8.60M
10-Q · filed 2018-02-06
-$18.20M
10-Q · filed 2018-02-06
-$24.90M
derived: sum of 3 quarters · filed 2018-02-06
-$30.10M
derived: sum of 4 quarters · filed 2018-02-06
2016-09-30-$9.60M
10-Q · filed 2017-11-07
-$16.30M
derived: sum of 2 quarters · filed 2017-11-07
-$21.50M
derived: sum of 3 quarters · filed 2017-11-07
-$28.00M
derived: sum of 4 quarters · filed 2017-11-07
2016-06-30-$6.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01
-$11.90M
derived: sum of 2 quarters · filed 2017-09-01
-$18.40M
derived: sum of 3 quarters · filed 2017-09-01
-$25.20M
10-K · filed 2017-09-01
2016-03-31-$5.20M
10-Q · filed 2017-05-08
-$11.70M
derived: sum of 2 quarters · filed 2017-05-08
-$18.50M
10-Q · filed 2017-05-08
-$38.40M
derived: sum of 4 quarters · filed 2017-05-08
2015-12-31-$6.50M
10-Q · filed 2017-02-06
-$13.30M
10-Q · filed 2017-02-06
-$33.20M
derived: sum of 3 quarters · filed 2017-02-06
-$32.10M
derived: sum of 4 quarters · filed 2017-02-06
2015-09-30-$6.70M
10-Q · filed 2016-11-08
-$26.70M
derived: sum of 2 quarters · filed 2016-11-08
-$25.60M
derived: sum of 3 quarters · filed 2016-11-08
-$19.20M
derived: sum of 4 quarters · filed 2016-11-08
2015-06-30-$20.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
-$18.90M
derived: sum of 2 quarters · filed 2016-09-13
-$12.50M
derived: sum of 3 quarters · filed 2016-09-13
-$19.50M
10-K · filed 2016-09-13
2015-03-31$1.10M
10-Q · filed 2016-05-10
$7.50M
derived: sum of 2 quarters · filed 2016-05-10
$500.00K
10-Q · filed 2016-05-10
-$10.00M
derived: sum of 4 quarters · filed 2016-09-13
2014-12-31$6.40M
10-Q · filed 2016-02-08
-$600.00K
10-Q · filed 2016-02-08
-$11.10M
derived: sum of 3 quarters · filed 2016-09-13
-$7.90M
derived: sum of 4 quarters · filed 2016-09-13
2014-09-30-$7.00M
10-Q · filed 2015-11-06
-$17.50M
derived: sum of 2 quarters · filed 2016-09-13
-$14.30M
derived: sum of 3 quarters · filed 2016-09-13
-$14.40M
derived: sum of 4 quarters · filed 2016-09-13
2014-06-30-$10.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13
-$7.30M
derived: sum of 2 quarters · filed 2016-09-13
-$7.40M
derived: sum of 3 quarters · filed 2016-09-13
-$11.50M
10-K · filed 2016-09-13
2014-03-31$3.20M
10-Q · filed 2015-05-08
$3.10M
derived: sum of 2 quarters · filed 2015-05-08
-$1.00M
10-Q · filed 2015-05-08
-$7.40M
derived: sum of 4 quarters · filed 2015-09-11
2013-12-31-$100.00K
10-Q · filed 2015-02-06
-$4.20M
10-Q · filed 2015-02-06
-$10.60M
derived: sum of 3 quarters · filed 2015-09-11
-$10.60M
derived: sum of 4 quarters · filed 2015-09-11
2013-09-30-$4.10M
10-Q · filed 2014-11-07
-$10.50M
derived: sum of 2 quarters · filed 2015-09-11
-$10.50M
derived: sum of 3 quarters · filed 2015-09-11
-$18.30M
derived: sum of 4 quarters · filed 2015-09-11
2013-06-30-$6.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11
-$6.40M
derived: sum of 2 quarters · filed 2015-09-11
-$14.20M
derived: sum of 3 quarters · filed 2015-09-11
-$22.10M
10-K · filed 2015-09-11
2013-03-31$0.00
10-Q · filed 2014-05-12
$30.00K
10-Q · filed 2013-05-10
-$7.80M
derived: sum of 2 quarters · filed 2014-05-12
-$15.70M
10-Q · filed 2014-05-12
-$15.67M
10-Q · filed 2013-05-10
-$18.48M
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31-$7.80M
10-Q · filed 2014-02-10
-$7.83M
10-Q · filed 2013-02-11
-$15.70M
10-Q · filed 2014-02-10
-$15.70M
10-Q · filed 2013-02-11
-$18.48M
derived: sum of 3 quarters · filed 2014-02-10
-$21.11M
derived: sum of 4 quarters · filed 2014-02-10
2012-09-30-$7.80M
10-Q · filed 2013-11-12
-$4.12M
10-Q · filed 2012-11-08
-$10.68M
derived: sum of 2 quarters · filed 2013-11-12
-$9.16M
10-Q · filed 2012-11-08
-$21.72M
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30-$2.88M
10-Q · filed 2012-08-09
-$5.04M
10-Q · filed 2012-08-09
-$13.92M
derived: sum of 3 quarters · filed 2013-05-10
-$22.90M
10-K · filed 2014-09-30
2012-03-31-$2.63M
10-Q · filed 2013-05-10
-$2.16M
10-Q · filed 2012-05-10
-$11.05M
derived: sum of 2 quarters · filed 2013-05-10
-$16.36M
10-Q · filed 2013-05-10
-$20.67M
derived: sum of 4 quarters · filed 2013-05-10
2011-12-31-$8.42M
10-Q · filed 2013-02-11
-$13.73M
10-Q · filed 2013-02-11
-$18.04M
derived: sum of 3 quarters · filed 2013-02-11
-$9.76M
10-K · filed 2012-03-14
2011-09-24-$4.94M
10-Q · filed 2012-11-08
-$9.62M
derived: sum of 2 quarters · filed 2012-08-09
-$7.75M
10-Q · filed 2012-11-08
-$14.13M
derived: sum of 4 quarters · filed 2012-08-09
2011-06-30-$30.50M
10-K · filed 2013-09-27
2011-06-25-$4.69M
10-Q · filed 2012-08-09
-$2.82M
10-Q · filed 2012-08-09
-$9.20M
derived: sum of 3 quarters · filed 2012-08-09
-$5.92M
derived: sum of 4 quarters · filed 2012-08-09
2011-03-26$1.87M
10-Q · filed 2012-05-10
-$4.51M
derived: sum of 2 quarters · filed 2012-05-10
-$1.23M
derived: sum of 3 quarters · filed 2012-05-10
-$4.72M
derived: sum of 4 quarters · filed 2012-05-10
2010-12-25-$6.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14
-$3.10M
derived: sum of 2 quarters · filed 2012-03-14
-$6.59M
derived: sum of 3 quarters · filed 2012-03-14
-$1.20M
10-K · filed 2012-03-14
2010-09-25$3.28M
10-Q · filed 2011-11-02
-$211.00K
derived: sum of 2 quarters · filed 2011-11-02
$5.18M
10-Q · filed 2011-11-02
2010-06-26-$3.49M
10-Q · filed 2011-08-03
$1.91M
10-Q · filed 2011-08-03
2009-12-26-$17.98M
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B